Loading
RapidAI
RapidAI is a leader in deep clinical artificial intelligence, focusing on advanced imaging solutions for critical vascular and neurovascular conditions, including acute stroke and intracranial hemorrhage. Founded in 2011 and based in Menlo Park, California, with operations in Golden, Colorado, the company has developed a clinically validated platform that is FDA-cleared and utilized in over 1,600 hospitals across more than 60 countries. The company offers a suite of AI-driven clinical decision support services that enhance the workflow for stroke and neurovascular care. RapidAI's technology integrates seamlessly into hospital systems, providing real-time data access and collaboration tools for clinical teams. Its products include specialized software for analyzing CT and MRI scans, enabling precise detection and quantification of various conditions. RapidAI is committed to improving patient outcomes and operational efficiencies in healthcare through its innovative solutions.
Funding
Every round, secondary, debt facility or acquisition involving RapidAI that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$15M